Allergy and Immunology · San Diego, CA
NPI
1205194198
Since 2012
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
200 W Arbor Dr
San Diego, CA, 92103
Phone (800) 926-8273
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
1,659 services
Medicare patients, 2024
178
Average age 70
Drug cost, 2024
$1.4M
1,223 prescriptions
Company payments, 2024
$111
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tukisa D Smith was code 95004 (test - miscellaneous), 1,001 times for 30 patients. In total Tukisa D Smith billed 1,659 services in 20 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,001 | 30 | $3.08 | $3,079 |
| 99215 Office E&M - Established | Office | 120 | 75 | $145.50 | $17K |
| 95117 Treatment - Miscellaneous | Office | 57 | 13 | $8.52 | $486 |
| 99214 Office E&M - Established | Office | 54 | 42 | $102.13 | $5,515 |
| 99205 Office E&M - New | Office | 46 | 46 | $157.03 | $7,224 |
| 36415 Venipuncture Blood Collection | Office | 18 | 18 | $8.65 | $156 |
By year: 2022 $38K for 2,015 services; 2023 $41K for 1,917 services; 2024 $38K for 1,659 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 18 | 18 | $8.65 | $156 |
Medicare prescription drug claims, 2024
In 2024, the drug Tukisa D Smith prescribed most often to Medicare patients was Azelastine Hcl, with 306 prescriptions and refills. In total Tukisa D Smith wrote 1,223 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 306 | 551 | 100 | $7,759 |
| Ipratropium Bromide Generic | 231 | 386 | 73 | $9,725 |
| Fluticasone Propionate Generic | 177 | 353 | 64 | $2,428 |
| Montelukast Sodium Generic | 110 | 303 | 37 | $1,355 |
| Levocetirizine Dihydrochloride Generic | 63 | 73 | Under 11 | $1,008 |
| Dupixent Syringe Dupilumab | 28 | 28 | Under 11 | $100K |
| Dupixent Pen Dupilumab | 28 | 28 | Under 11 | $102K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 27 | 28 | Under 11 | $895 |
| Famotidine Generic | 24 | 30 | Under 11 | $162 |
| Epinephrine Generic | 20 | 22 | 19 | $3,725 |
| Qvar Redihaler Beclomethasone Dipropionate | 16 | 19 | Under 11 | $3,641 |
| Orladeyo Berotralstat Hydrochloride | 15 | 15 | Under 11 | $618K |
| Sajazir Icatibant Acetate | 11 | 11 | Under 11 | $99K |
| Fluticasone Propionate Hfa Fluticasone Propionate | 11 | 11 | Under 11 | $1,837 |
Brand drugs: 210 claims; generic drugs: 1,013 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Tukisa D Smith $111 ($111 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $111.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.